Jiangsu Yuyue Medical Equipment & Supply Co Ltd (002223) - Net Assets

Latest as of September 2025: CN¥13.64 Billion CNY ≈ $2.00 Billion USD

Based on the latest financial reports, Jiangsu Yuyue Medical Equipment & Supply Co Ltd (002223) has net assets worth CN¥13.64 Billion CNY (≈ $2.00 Billion USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥16.67 Billion ≈ $2.44 Billion USD) and total liabilities (CN¥3.04 Billion ≈ $444.27 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Jiangsu Yuyue Medical Equipment & Supply liquid asset ratio to evaluate the company's liquid asset resilience ratio.

Key Net Assets Metrics

Metric Value
Current Net Assets CN¥13.64 Billion
% of Total Assets 81.79%
Annual Growth Rate 26.58%
5-Year Change 68.84%
10-Year Change 493.48%
Growth Volatility 49.3

Jiangsu Yuyue Medical Equipment & Supply Co Ltd - Net Assets Trend (2005–2024)

This chart illustrates how Jiangsu Yuyue Medical Equipment & Supply Co Ltd's net assets have evolved over time, based on quarterly financial data. Also explore balance sheet size of Jiangsu Yuyue Medical Equipment & Supply for the complete picture of this company's asset base.

Annual Net Assets for Jiangsu Yuyue Medical Equipment & Supply Co Ltd (2005–2024)

The table below shows the annual net assets of Jiangsu Yuyue Medical Equipment & Supply Co Ltd from 2005 to 2024. For live valuation and market cap data, see Jiangsu Yuyue Medical Equipment & Supply (002223) market capitalisation.

Year Net Assets Change
2024-12-31 CN¥12.65 Billion
≈ $1.85 Billion
+6.20%
2023-12-31 CN¥11.92 Billion
≈ $1.74 Billion
+18.37%
2022-12-31 CN¥10.07 Billion
≈ $1.47 Billion
+19.42%
2021-12-31 CN¥8.43 Billion
≈ $1.23 Billion
+12.47%
2020-12-31 CN¥7.49 Billion
≈ $1.10 Billion
+21.74%
2019-12-31 CN¥6.16 Billion
≈ $900.88 Million
+11.03%
2018-12-31 CN¥5.54 Billion
≈ $811.36 Million
-0.47%
2017-12-31 CN¥5.57 Billion
≈ $815.20 Million
+12.88%
2016-12-31 CN¥4.94 Billion
≈ $722.16 Million
+131.45%
2015-12-31 CN¥2.13 Billion
≈ $312.01 Million
+21.04%
2014-12-31 CN¥1.76 Billion
≈ $257.78 Million
+16.13%
2013-12-31 CN¥1.52 Billion
≈ $221.97 Million
+15.66%
2012-12-31 CN¥1.31 Billion
≈ $191.91 Million
+18.44%
2011-12-31 CN¥1.11 Billion
≈ $162.04 Million
+25.91%
2010-12-31 CN¥879.47 Million
≈ $128.69 Million
+82.27%
2009-12-31 CN¥482.51 Million
≈ $70.61 Million
+18.94%
2008-12-31 CN¥405.69 Million
≈ $59.36 Million
+196.10%
2007-12-31 CN¥137.01 Million
≈ $20.05 Million
-11.14%
2006-12-31 CN¥154.18 Million
≈ $22.56 Million
+7.32%
2005-12-31 CN¥143.67 Million
≈ $21.02 Million
--

Equity Component Analysis

This analysis shows how different components contribute to Jiangsu Yuyue Medical Equipment & Supply Co Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have grown by 15759.2% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2024)

Component Amount Percentage
Retained Earnings CN¥9.02 Billion 71.92%
Common Stock CN¥1.00 Billion 8.00%
Other Comprehensive Income CN¥828.00 Million 6.61%
Other Components CN¥1.69 Billion 13.48%
Total Equity CN¥12.54 Billion 100.00%

Jiangsu Yuyue Medical Equipment & Supply Co Ltd Competitors by Market Cap

The table below lists competitors of Jiangsu Yuyue Medical Equipment & Supply Co Ltd ranked by their market capitalization.

Company Market Cap
Far Eastern New Century Corp
TW:1402
$4.40 Billion
Suven Pharmaceuticals Limited
NSE:SUVENPHAR
$4.40 Billion
IPG Photonics Corporation
NASDAQ:IPGP
$4.40 Billion
Jiangxi Jovo Energy Co. Ltd
SHG:605090
$4.40 Billion
Novanta Inc
F:1GSN
$4.40 Billion
MDU Resources Group Inc
NYSE:MDU
$4.40 Billion
Clear Secure Inc
NYSE:YOU
$4.40 Billion
Inner Mongolia ERDOS Resources Co Ltd
SHG:600295
$4.40 Billion

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Jiangsu Yuyue Medical Equipment & Supply Co Ltd's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2023 to 2024, total equity changed from 11,763,562,138 to 12,535,332,607, a change of 771,770,469 (6.6%).
  • Net income of 1,805,700,659 contributed positively to equity growth.
  • Dividend payments of 1,224,455,405 reduced retained earnings.
  • Other comprehensive income increased equity by 86,974,228.

Equity Change Factors (2023 to 2024)

Factor Impact Contribution
Net Income CN¥1.81 Billion +14.4%
Dividends Paid CN¥1.22 Billion -9.77%
Other Comprehensive Income CN¥86.97 Million +0.69%
Other Changes CN¥103.55 Million +0.83%
Total Change CN¥- 6.56%

Book Value vs Market Value Analysis

This analysis compares Jiangsu Yuyue Medical Equipment & Supply Co Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 2.39x
  • The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
  • The price-to-book ratio has decreased from 266.50x to 2.39x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2005-12-31 CN¥0.11 CN¥30.00 x
2006-12-31 CN¥0.14 CN¥30.00 x
2007-12-31 CN¥0.24 CN¥30.00 x
2008-12-31 CN¥0.51 CN¥30.00 x
2009-12-31 CN¥0.57 CN¥30.00 x
2010-12-31 CN¥1.01 CN¥30.00 x
2011-12-31 CN¥1.62 CN¥30.00 x
2012-12-31 CN¥1.49 CN¥30.00 x
2013-12-31 CN¥1.73 CN¥30.00 x
2014-12-31 CN¥2.00 CN¥30.00 x
2015-12-31 CN¥2.40 CN¥30.00 x
2016-12-31 CN¥5.21 CN¥30.00 x
2017-12-31 CN¥5.22 CN¥30.00 x
2018-12-31 CN¥5.49 CN¥30.00 x
2019-12-31 CN¥6.06 CN¥30.00 x
2020-12-31 CN¥7.42 CN¥30.00 x
2021-12-31 CN¥8.31 CN¥30.00 x
2022-12-31 CN¥9.95 CN¥30.00 x
2023-12-31 CN¥11.83 CN¥30.00 x
2024-12-31 CN¥12.57 CN¥30.00 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Jiangsu Yuyue Medical Equipment & Supply Co Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 14.40%
  • The company shows good efficiency in utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 23.87%
  • • Asset Turnover: 0.48x
  • • Equity Multiplier: 1.25x
  • Recent ROE (14.40%) is below the historical average (19.33%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2005 52.00% 27.65% 0.66x 2.83x CN¥47.47 Million
2006 21.86% 13.60% 0.59x 2.73x CN¥17.12 Million
2007 27.56% 13.08% 1.07x 1.97x CN¥24.13 Million
2008 15.23% 15.41% 0.89x 1.11x CN¥21.24 Million
2009 21.14% 18.69% 0.84x 1.34x CN¥52.99 Million
2010 18.45% 18.20% 0.83x 1.22x CN¥73.69 Million
2011 20.61% 19.48% 0.90x 1.18x CN¥116.58 Million
2012 18.76% 18.60% 0.85x 1.18x CN¥113.95 Million
2013 17.13% 18.12% 0.79x 1.20x CN¥107.41 Million
2014 16.97% 17.66% 0.79x 1.22x CN¥121.98 Million
2015 17.22% 17.32% 0.72x 1.38x CN¥152.76 Million
2016 10.17% 18.93% 0.45x 1.18x CN¥8.47 Million
2017 11.30% 16.72% 0.53x 1.26x CN¥67.93 Million
2018 13.30% 17.38% 0.61x 1.26x CN¥180.34 Million
2019 12.40% 16.23% 0.58x 1.31x CN¥145.51 Million
2020 23.65% 26.15% 0.67x 1.36x CN¥1.02 Billion
2021 17.92% 21.50% 0.57x 1.45x CN¥655.21 Million
2022 16.18% 22.46% 0.47x 1.53x CN¥609.04 Million
2023 20.37% 30.05% 0.50x 1.36x CN¥1.22 Billion
2024 14.40% 23.87% 0.48x 1.25x CN¥552.17 Million

Industry Comparison

This section compares Jiangsu Yuyue Medical Equipment & Supply Co Ltd's net assets metrics with peer companies in the Medical Devices industry.

Industry Context

  • Industry: Medical Devices
  • Average net assets among peers: $1,392,161,418
  • Average return on equity (ROE) among peers: 20.19%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Jiangsu Yuyue Medical Equipment & Supply Co Ltd (002223) CN¥13.64 Billion 52.00% 0.22x $4.40 Billion
Shanghai Kehua Bio-Engineering Co Ltd (002022) $380.71 Million 14.82% 0.20x $456.11 Million
Double Medical Technology Inc (002901) $2.13 Billion 28.38% 0.24x $2.54 Billion
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A (002932) $2.85 Billion 49.59% 0.20x $584.21 Million
Lepu Medical Tech Beijing (300003) $1.76 Billion 16.64% 0.06x $3.91 Billion
INKON Life Technology Co Ltd (300143) $643.30 Million 0.00% 0.61x $1.25 Billion
Edan Instruments Inc (300206) $1.81 Billion 36.02% 0.25x $1.26 Billion
Guangdong Biolight Meditech Co Ltd (300246) $504.27 Million 13.31% 0.36x $724.39 Million
Beijing Leadman Biochemistry Co Ltd (300289) $1.34 Billion 5.21% 0.24x $537.34 Million
Sinocare Inc (300298) $1.11 Billion 17.76% 0.09x $1.40 Billion

About Jiangsu Yuyue Medical Equipment & Supply Co Ltd

SHE:002223 China Medical Devices
Market Cap
$4.40 Billion
CN¥30.07 Billion CNY
Market Cap Rank
#3950 Global
#666 in China
Share Price
CN¥30.00
Change (1 day)
+0.91%
52-Week Range
CN¥29.08 - CN¥45.40
All Time High
CN¥45.40
About

Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. engages provision of home medical devices, medical clinical products, and related services in China and internationally. It offers respiratory solutions, including PAP therapy, oxygen concentrators, nebulizers, high flow oxygen therapy, and airway clearances; diabetes management solutions; medical diagnostic devices, such as blood pressure monito… Read more